camptothecin has been researched along with arabinofuranosylcytosine triphosphate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akiyama, Y; Furusho, K; Kataoka, A; Koishi, S; Kubota, M; Lin, YW; Sawada, M; Usami, I; Watanabe, Ki | 1 |
Abdel-Aziz, W; Hickey, RJ; Malkas, LH | 1 |
2 other study(ies) available for camptothecin and arabinofuranosylcytosine triphosphate
Article | Year |
---|---|
Apoptosis-resistant phenotype selected by alternating exposure to camptothecin and etoposide.
Topics: Antineoplastic Agents; Apoptosis; Arabinofuranosylcytosine Triphosphate; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-X Protein; Calcimycin; Camptothecin; Clone Cells; Cycloheximide; Cytarabine; DNA Fragmentation; Drug Resistance, Neoplasm; Etoposide; HL-60 Cells; Humans; Hydroxyurea; Kinetics; Nucleosomes; Phenotype; Proto-Oncogene Proteins c-bcl-2; Ultraviolet Rays | 1997 |
An in vitro model system that can differentiate the stages of DNA replication affected by anticancer agents.
Topics: Antineoplastic Agents; Arabinofuranosylcytosine Triphosphate; Camptothecin; Cytarabine; DNA Replication; DNA-Directed DNA Polymerase; DNA, Viral; Doxorubicin; Electrophoresis, Agar Gel; Humans; Multienzyme Complexes; Simian virus 40 | 2004 |